Travelers Vaccines Market, Size, Share, Opportunities and Forecast, 2020-2027

SKU: DHC404 | Last Updated On: Mar 09 2021 | No. of Pages: 180 | Available Formats

> Global Travelers Vaccines Market Expected to reach a high CAGR of 8.60% By 2027: DataM Intelligence

Global Travelers Vaccines Market Is Segmented By Type Segment (Meningococcal Vaccine, Japanese Encephalitis Vaccine, Yellow Fever Vaccine, Hepatitis Vaccine, Cholera Vaccine, Others), By Application Segment (Tourists, Students, Workers, Others) And By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2020-2027

 

Market Overview

The Global Travelers Vaccines Market is expected to grow at a CAGR of 8.60% during the forecasting period (2020-2027).

A vaccines are a biological preparation that aids to fight against diseases and boost up the immunity. It contains an agent that is related to a disease causing organism and made from killed form of microbes. According to the World Health Organization (WHO), currently licensed vaccines are available to avoid over twenty five infections. The effectiveness of the vaccine depends on disease pathophysiology, the stain of the vaccine, ethnicity, the schedule of the vaccination, and genetic predisposition. As the globalization is rising, the international traveling will keep increasing, which in turn, creates the demand for travel vaccines. Moreover, the vaccines are broadly used as a preventive measure counter to the known infectious diseases. The travelers are educated to adhere to the region-specific immunization plan.

Overview

Source: DataM Intelligence Analysis (2019)

Market Dynamics

The increase in the number of diseases and viruses that have afflicted the sector has increased swiftly in the past few decades, and certainly, not enough vaccinations have been developed against them. Now, the increased awareness has obliged people to take the necessary vaccinations available, without giving it a second thought.

Growing tourism and travel industry

Growing touring industry and surge in incidence of travel related diseases is the major growth driver for the traveler vaccine market. Growing investment for R&D of new vaccine by pharmaceutical and biotechnology companies and growing adoption of vaccine by international travelers has prompted the demand for traveler vaccines. Furthermore, the growing government initiatives and rising awareness through electronic & print media are the factors that are expected to enhance the growth of the market. However, lack of expertise for the production of vaccines and weak cold supply chain management are the factors that are limiting the growth of the market.

Low risk of serious side effects

Extreme low risk of serious side effects on fetus along with the suitable educational & awareness programs through the various nonprofit organization are factors that support the market gfowth. Rising inclinations for outsourcing of vaccine in the emerging and under developed countries offers opportunity to boosts the traveler’s vaccines market. It is expected to grow with the increase in outbound travel and increase in vaccination coverage due to its awareness.

COVID-19 Impact Analysis

COVID-19 has certainly hampered the growth of the travelers vaccine globally. The ban on the international travelling by the governments has declined the number of international visits in 2020. Therefore, the demand for travelers vaccine declined and led to the downfall in the maket value in 2020 and subsequent years. Post COVID-19, it is expected that the travel and tourism industry get boom and the demand for travelers vaccine also will gain traction due to increasing concern of health safety. Travelers vaccines have a very rapid growth in the upcoimg year due to this pandemic.

Segmentation Analysis

Travelers vaccines is further segmented on the basis of application which includes tourists, students, workers and others

Tourists segment is expected to be the fastest growing segment

Tourist segment is anticipated to grow with high CAGR over the forecast period. The number of international tourist arrivals globally increased from 1.0 billion in 2012 to nearly 1.4 billion in 2018. A large number of these travelers journey starts with the developed countries to regions with endemic diseases. Moreover, regulatory authorities globally have also instructed that travelers should be vaccinated before traveling to disease-prone regions.

Based on the type, the travelers vaccines market has been classified into Meningococcal Vaccine, Japanese Encephalitis Vaccine, Yellow Fever Vaccine, Hepatitis Vaccine, Cholera Vaccine and Others 

Hepatitis Vaccine is become popular іn glоbаl travlers vaccine mаrkеt.

A key drive for the hepatitis vaccine market comes from the increasing prevalence of HBV infected populations, particularly in the WHO Western Pacific Region. Governments globally over recognize HBV vaccine as the only cost-effective way to primary prevention of the infection.

Geographical Analysis

Based on geography, the study analyzes the travelers vaccines market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North America is anticipated to hold largest share in the global travelers vaccines market

Geographically, the North America is likely to dominate the human vaccines market in the global market over the forecast period. The combination vaccines segment is expected to expand at a high share in North America, followed by the recombinant vaccines and attenuated vaccines segments. In Europe, increase in demand for vaccination and increase in R&D expenditure boost the traveler’s vaccines market. Moreover, Asia Pacific is an emerging market for traveler’s vaccine due to the improving healthcare infrastructure and rising government expenditures by organizing educational & awareness programs. In Middle East and African countries, the advancement of the healthcare industry and economy help to enhance traveler’s vaccine market. However, affordability issues are factors restraining the market growth. The Government of Saudi Arabia operates routine vaccination programs for influenza, flu, and other vaccines in the country that generate an opportunity in the traveler’s vaccine market.

Competitive Landscape

The travelers vaccines market is highly competitive, owing to the presence of big food brands. The key travelers vaccines players which are contributing to the growth of the global market include Baxter International, Abbott Laboratories, Crucell Vaccines, Pfizer Inc., Emergent BioSolutions, Hoffman-La Roche Ltd., Dynavax Technologies Corporation, GSK group of companies, Shenzhen Kangtay Biological Products Co. Ltd., Takeda Pharmaceuticals U.S.A. Inc., Zydus Cadila, among others. The major players are adopting new product launch and expansion strategies for global growth in the travelers vaccines market.   

Baxter International, Inc.:

Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions. Baxter International, Inc. has a product portfolio comprising essential renal and hospital products, including sterile IV solutions, acute and chronic dialysis, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software and services. The company operates through the following segment: Europe, Americas, Middle East & Africa and Asia-Pacific.

Product Portfolio: The Company’s portfolio comprises critical care, hospital care, nutritional care, renal care and surgical care, among others. Baxter's Medical Products business produces intravenous products and other products used in the delivery of fluids and drugs to patients; inhalational anaesthetics; contract manufacturing services; and products to treat end-stage kidney disease, or irreversible kidney failure, including products for peritoneal dialysis and hemodialysis.

Why Purchase the Report?

  • Visualize the travelers vaccines market segmentation composition by application, type and region, highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the travelers vaccines market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of travelers vaccines market - level 3 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global travelers vaccines market report would provide access to an approx. 51 market data table, 49 figures and 250 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Suggestions for Related Market Report:

  • Global Vaccine Market
  • Global Vaccine Kit market
  • Global Injection Market
  • Global Syringe Market

 

Table of Contents

  1. Travelers Vaccines Market Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Travelers Vaccines Market – Market Definition and Overview

  3. Travelers Vaccines Market – Executive Summary

    1. Market Snippet by Type
    2. Market Snippet by Application
    3. Market Snippet by Region
  4. Travelers Vaccines Market – Market Dynamics

    1. Market Impacting Factors
      1. Drivers
        1. Growing tourism and travel industry
      2. Restraints:
        1. Low risk of side effects
      3. Impact Analysis
  5. Travelers Vaccines Market – Industry Analysis

    1. Porter's Five Forces Analysis
    2. Supply Chain Analysis
    3. Value Chain Analysis
    4. PEST Analysis
    5. Pricing Analysis
    6. Regulatory Analysis
    7. Reimbursement Analysis
    8. Unmet Needs
    9. Patent Trends
  6. Travelers Vaccines Market – COVID-19 Analysis

    1. Analysis of Covid-19 on the Market
      1. Before COVID-19 Market Scenario
      2. Present COVID-19 Market Scenario
      3. After COVID-19 or Future Scenario
    2. Pricing Dynamics Amid Covid-19
    3. Demand-Supply Spectrum
    4. Government Initiatives Related to the Market During Pandemic
    5. Manufacturers Strategic Initiatives
    6. Conclusion 
  7. Travelers Vaccines Market – By Type

    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
    3. Market Attractiveness Index, By Type Segment
      1. Meningococcal Vaccine*
        1. Introduction
        2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
      2. Japanese Encephalitis Vaccine
      3. Yellow Fever Vaccine
      4. Hepatitis Vaccine
      5. Cholera Vaccine
      6. Others
  8. Travelers Vaccines Market – By Application

    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    3. Market Attractiveness Index, By Application Segment
      1. Tourists*
        1. Introduction
        2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
      2. Students
      3. Workers
      4. Others
  9. Travelers Vaccines Market – By Region
    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    3. Market Attractiveness Index, By Region
    4. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. U.S.
        2. Canada
        3. Mexico
    5. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    6. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    7. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    8. Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  10. Travelers Vaccines Market – Competitive Landscape

    1. Competitive Scenario
    2. Market Positioning/Share Analysis
    3. Mergers and Acquisitions Analysis
  11. Travelers Vaccines Market- Company Profiles

    1. Baxter International*
      1. Company Overview
      2. Product Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. Abbott Laboratories
    3. Crucell Vaccines
    4. Pfizer Inc.
    5. Emergent BioSolutions
    6. Hoffman-La Roche Ltd.
    7. Dynavax Technologies Corporation
    8. GSK group of companies
    9. Shenzhen Kangtay Biological Products Co. Ltd.
    10. Takeda Pharmaceuticals U.S.A. Inc
    11. Zydus Cadila (List Not Exhaustive)
  12. Travelers Vaccines Market – Premium Insights

  13. Travelers Vaccines Market – DataM Intelligence

    1. Appendix
    2. About Us and Services
    3. Contact Us

 

List of Tables & Figures

List of Tables

Table 1 Global Travelers Vaccines Market Value, By Type, 2019, 2023 & 2027 (US$ Million)

Table 2 Global Travelers Vaccines Market Value, By Application, 2019, 2023 & 2027 (US$ Million)

Table 3 Global Travelers Vaccines Market Value, By Region, 2019, 2023 & 2027 (US$ Million)

Table 4 North America Travelers Vaccines Market Value, By Type, 2019, 2023 & 2027 (US$ Million)

Table 5 North America Travelers Vaccines Market Value, By Application, 2019, 2023 & 2027 (US$ Million)

Table 6 North America Travelers Vaccines Market Value, By Country, 2018-2027 (US$ Million)

Table 7 South America Travelers Vaccines Market Value, By Type, 2019, 2023 & 2027 (US$ Million)

Table 8 South America Travelers Vaccines Market Value, By Application, 2019, 2023 & 2027 (US$ Million)

Table 9 South America Travelers Vaccines Market Value, By Country, 2018-2027 (US$ Million)

Table 10 Europe Travelers Vaccines Market Value, By Type, 2019, 2023 & 2027 (US$ Million)

Table 11 Europe Travelers Vaccines Market Value, By Application, 2019, 2023 & 2027 (US$ Million)

Table 12 Europe Travelers Vaccines Market Value, By Country, 2018-2027 (US$ Million)

Table 13 Asia Pacific Travelers Vaccines Market Value, By Type, 2019, 2023 & 2027 (US$ Million)

Table 14 Asia Pacific Travelers Vaccines Market Value, By Application, 2019, 2023 & 2027 (US$ Million)

Table 15 Asia Pacific Travelers Vaccines Market Value, By Country, 2019, 2023 & 2027 (US$ Million)

Table 16 The Middle East & Africa Travelers Vaccines Market Value, By Type, 2019, 2023 & 2027 (US$ Million)

Table 17 The Middle East & Africa Travelers Vaccines Market Value, By Application, 2019, 2023 & 2027 (US$ Million)

Table 18 The Middle East & Africa Travelers Vaccines Market Value, By Country, 2019, 2023 & 2027 (US$ Million)

Table 19 Baxter International: Overview

Table 20 Baxter International: Product Portfolio

Table 21 Baxter International: Key Developments

Table 22 Abbott Laboratories: Overview

Table 23 Abbott Laboratories: Product Portfolio

Table 24 Abbott Laboratories: Key Developments

Table 25 Crucell Vaccines: Overview

Table 26 Crucell Vaccines: Product Portfolio

Table 27 Crucell Vaccines: Key Developments

Table 28 Pfizer Inc.: Overview

Table 29 Pfizer Inc.: Product Portfolio

Table 30 Pfizer Inc.: Key Developments

Table 31 Emergent BioSolutions: Overview

Table 32 Emergent BioSolutions: Product Portfolio

Table 33 Emergent BioSolutions: Key Developments

Table 34 Hoffman-La Roche Ltd. : Overview

Table 35 Hoffman-La Roche Ltd. : Product Portfolio

Table 36 Hoffman-La Roche Ltd. : Key Developments

Table 37 Dynavax Technologies Corporation: Overview

Table 38 Dynavax Technologies Corporation: Product Portfolio

Table 39 Dynavax Technologies Corporation: Key Developments

Table 40 GSK group of companies: Overview

Table 41 GSK group of companies: Product Portfolio

Table 42 GSK group of companies: Key Developments

Table 43 Shenzhen Kangtay Biological Products Co. Ltd.: Overview

Table 44 Shenzhen Kangtay Biological Products Co. Ltd.: Product Portfolio

Table 45 Shenzhen Kangtay Biological Products Co. Ltd.: Key Developments

Table 46 Takeda Pharmaceuticals U.S.A. Inc: Overview

Table 47 Takeda Pharmaceuticals U.S.A. Inc: Product Portfolio

Table 48 Takeda Pharmaceuticals U.S.A. Inc: Key Developments

Table 49 Zydus Cadila: Overview

Table 50 Zydus Cadila: Product Portfolio

Table 51 Zydus Cadila: Key Developments

 

List of Figures

Figure 1 Global Travelers Vaccines Market Share, By Type, 2019 & 2027 (%)

Figure 2 Global Travelers Vaccines Market Share, By Application, 2019 & 2027 (%)

Figure 3 Global Travelers Vaccines Market Share, By Region, 2019 & 2027 (%)

Figure 4 Global Travelers Vaccines Market Value, 2018-2027 (US$ Million)

Figure 5 Global Travelers Vaccines Market Y-o-Y Growth, By Type, 2019-2027 (%)

Figure 6 Meningococcal Vaccine: Global Travelers Vaccines Market Value, 2018-2027 (US$ Million)

Figure 7 Japanese Encephalitis Vaccine: Global Travelers Vaccines Market Value, 2018-2027 (US$ Million)

Figure 8 Yellow Fever Vaccine: Global Travelers Vaccines Market Value, 2018-2027 (US$ Million)

Figure 9 Hepatitis Vaccine: Global Travelers Vaccines Market Value, 2018-2027 (US$ Million)

Figure 10 Cholera Vaccine: Global Travelers Vaccines Market Value, 2018-2027 (US$ Million)

Figure 11 Others: Global Travelers Vaccines Market Value, 2018-2027 (US$ Million)

Figure 12 Global Travelers Vaccines Market Y-o-Y Growth, By Application, 2019-2027 (%)

Figure 13 Tourists: Global Travelers Vaccines Market Value, 2018-2027 (US$ Million)

Figure 14 Students: Global Travelers Vaccines Market Value, 2018-2027 (US$ Million)

Figure 15 Workers: Global Travelers Vaccines Market Value, 2018-2027 (US$ Million)

Figure 16 Others: Global Travelers Vaccines Market Value, 2018-2027 (US$ Million)

Figure 17 Global Travelers Vaccines Market Y-o-Y Growth, By Region, 2019-2027 (%)

Figure 18 North America Travelers Vaccines Market Value, 2018-2027 (US$ Million)

Figure 19 North America Travelers Vaccines Market Share, By Type, 2019 & 2027 (%)

Figure 20 North America Travelers Vaccines Market Share, By Application, 2019 & 2027 (%)

Figure 21 North America Travelers Vaccines Market Share, By Type, 2019 & 2027 (%)

Figure 22 North America Travelers Vaccines Market Share, By Country, 2019 & 2027 (%)

Figure 23 South America Travelers Vaccines Market Value, 2018-2027 (US$ Million)

Figure 24 South America Travelers Vaccines Market Share, By Type, 2019 & 2027 (%)

Figure 25 South America Travelers Vaccines Market Share, By Application, 2019 & 2027 (%)

Figure 26 South America Travelers Vaccines Market Share, By Country, 2019 & 2027 (%)

Figure 27 Europe Travelers Vaccines Market Value, 2018-2027 (US$ Million)

Figure 28 Europe Travelers Vaccines Market Share, By Type, 2019 & 2027 (%)

Figure 29 Europe Travelers Vaccines Market Share, By Application, 2019 & 2027 (%)

Figure 30 Europe Travelers Vaccines Market Share, By Country, 2019 & 2027 (%)

Figure 31 Asia-Pacific Travelers Vaccines Market Value, 2018-2027 (US$ Million)

Figure 32 Asia-Pacific Travelers Vaccines Market Share, By Type, 2019 & 2027 (%)

Figure 33 Asia-Pacific Travelers Vaccines Market Share, By Application, 2019 & 2027 (%)

Figure 34 Asia-Pacific Travelers Vaccines Market Share, By Country, 2019 & 2027 (%)

Figure 35 The Middle East & Africa Travelers Vaccines Market Value, 2018-2027 (US$ Million)

Figure 36 The Middle East & Africa Travelers Vaccines Market Share, By Type, 2019 & 2027 (%)

Figure 37 The Middle East & Africa Travelers Vaccines Market Share, By Application, 2019 & 2027 (%)

Figure 38 The Middle East & Africa Travelers Vaccines Market Share, By Country, 2019 & 2027 (%)

Figure 39 Baxter International: Financials

Figure 40 Abbott Laboratories: Financials

Figure 41 Crucell Vaccines: Financials

Figure 42 Pfizer Inc.: Financials

Figure 43 Emergent BioSolutions: Financials

Figure 44 Hoffman-La Roche Ltd. : Financials

Figure 45 Dynavax Technologies Corporation: Financials

Figure 46 GSK group of companies: Financials

Figure 47 Shenzhen Kangtay Biological Products Co. Ltd.: Financials

Figure 48 Takeda Pharmaceuticals U.S.A. Inc: Financials

Figure 49 Zydus Cadila: Financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Get your FREE SAMPLE PROPOSAL with a single click!

linkedinpinterest